Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Decoy Therapeutics Inc (DCOY)

Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Decoy Therapeutics Inc 2450 Holcombe Blvd. Suite X Houston TX 77021 USA

www.salariuspharma.com Employees: 2 P: 713-913-5608

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Decoy Therapeutics Inc. is a preclinical-stage biotechnology company which target serious unmet medical needs. The Company's initial pipeline is focused on respiratory viruses and GI cancers. Decoy Therapeutics Inc., formerly known as Salarius Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 4,776
Enterprise Value, $K 2,346
Shares Outstanding, K 6,384
Float, K 6,365
% Float 99.70%
Short Interest, K 1,072
Short Float 16.80%
Days to Cover 1.00
Short Volume Ratio 0.59
% of Insider Shareholders 0.30%
% of Institutional Shareholders 11.88%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -5,580 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -870 K
EBIT, $ -5,080 K
EBITDA, $ -5,070 K

Growth:

1-Year Return -97.33%
3-Year Return -99.73%
5-Year Return -99.99%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 98.63%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.81 on 11/14/25
Next Earnings Date 03/20/26
Earnings Per Share ttm -33.90
EPS Growth vs. Prev Qtr 73.17%
EPS Growth vs. Prev Year 84.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/18/25

DCOY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -401.05%
Return-on-Assets % -155.77%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.17
Book Value/Share 4.52
Interest Coverage -0.12
60-Month Beta 0.39
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar